Daniel J. Starks - Jul 27, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Daniel J. Starks by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Jul 27, 2023
Transactions value $
-$5,688,189
Form type
4
Date filed
7/28/2023, 05:10 PM
Previous filing
May 2, 2023
Next filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Sale -$2.37M -20.9K -0.31% $113.43 6.8M Jul 27, 2023 Direct F1
transaction ABT Common shares without par value Sale -$3.31M -29.1K -0.43% $114.01 6.78M Jul 27, 2023 Direct F2
holding ABT Common shares without par value 258 Jul 27, 2023 Alynne Starks 2012 Irrevocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.86 to $113.85, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.86 to $114.46, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.